MDR-TB Treatment & Prevention

Discussion Brief

Monthly examination of sputum samples is an important aspect of treatment monitoring for MDR-TB patients. Reviewing the patient’s cultures and smears provides information about the patient’s treatment response, and culture conversion determines the overall duration of MDR treatment, which should continue for a minimum of 18 months after conversion. The World Health Organization offers standardized definitions for MDR-TB treatment outcomes, including culture and smear conversion. However, because the frequency of bacteriological monitoring varies across programs, reporting recommendations are difficult to implement across all settings. 

A GHDonline member in Taiwan presented several cases and asked if each patient would be considered to have sputum conversion at 6 months according WHO guidelines. In the dialogue that followed, moderators and members clarified the meaning of “culture conversion at 6 months,” date of sputum conversion and time to conversion, but also shared important distinctions between the use in clinical care versus evaluations of program performance.
Sign in to read complete brief

• Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency update 2008
• Treatment of Tuberculosis: Guidelines for National Programmes
• Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
• Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study
• Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa

• TB Update from the CDC NPIN: Feb. 7-13, 2010
• Clinical Assistance in DR-TB
• Fwd: [tb-update] Week of July 25 to July 31, 2010
• [tb-update] Week of June 19 to June 25, 2011
• Fwd: [tb-update] Week of December 11 to December 17, 2011